Transatlantique Private Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Buy |
8,054
+496
| +7% | +$34.2K | 0.2% | 135 |
|
|
2025
Q1 | $524K | Buy |
7,558
+747
| +11% | +$51.7K | 0.21% | 139 |
|
|
2024
Q4 | $586K | Buy |
6,811
+640
| +10% | +$55.1K | 0.22% | 128 |
|
|
2024
Q3 | $734K | Buy |
6,171
+195
| +3% | +$23.2K | 0.28% | 108 |
|
|
2024
Q2 | $833K | Sell |
5,976
-433
| -7% | -$60.4K | 0.34% | 83 |
|
|
2024
Q1 | $822K | Buy |
6,409
+126
| +2% | +$16.2K | 0.36% | 98 |
|
|
2023
Q4 | $650K | Buy |
6,283
+267
| +4% | +$27.6K | 0.3% | 114 |
|
|
2023
Q3 | $547K | Sell |
6,016
-290
| -5% | -$26.4K | 0.29% | 113 |
|
|
2023
Q2 | $510K | Sell |
6,306
-1,264
| -17% | -$102K | 0.27% | 129 |
|
|
2023
Q1 | $602K | Buy |
7,570
+972
| +15% | +$77.3K | 0.33% | 98 |
|
|
2022
Q4 | $446K | Buy |
+6,598
| New | +$446K | 0.27% | 115 |
|